| 000 | 01720 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514231805.0 | ||
| 264 | 0 | _c20051202 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/01.STR.0000170644.15504.49 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChamorro, A | |
| 245 | 0 | 0 |
_aThe Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. _h[electronic resource] |
| 260 |
_bStroke _cJul 2005 |
||
| 300 |
_a1495-500 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBody Temperature |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Ischemia _xtherapy |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xpathology |
| 650 | 0 | 4 | _aIschemia |
| 650 | 0 | 4 |
_aLeukocytes _xcytology |
| 650 | 0 | 4 | _aLevofloxacin |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHorcajada, J P | |
| 700 | 1 | _aObach, V | |
| 700 | 1 | _aVargas, M | |
| 700 | 1 | _aRevilla, M | |
| 700 | 1 | _aTorres, F | |
| 700 | 1 | _aCervera, A | |
| 700 | 1 | _aPlanas, A M | |
| 700 | 1 | _aMensa, J | |
| 773 | 0 |
_tStroke _gvol. 36 _gno. 7 _gp. 1495-500 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.STR.0000170644.15504.49 _zAvailable from publisher's website |
| 999 |
_c15620287 _d15620287 |
||